15:30 , Jun 8, 2018 |  BC Week In Review  |  Company News

DRC approves compassionate use of investigational Ebola treatments

A Democratic Republic of the Congo ethics committee approved the use of five investigational Ebola therapies under compassionate use and expanded access. The World Health Organization said four of the five approved products are in the...
21:03 , Jun 6, 2018 |  BC Extra  |  Company News

DRC approves investigational Ebola treatments

A Democratic Republic of the Congo ethics committee approved the use of five investigational Ebola therapies under compassionate use and expanded access. The World Health Organization said four of the five approved products are in the...
23:43 , May 31, 2018 |  BC Extra  |  Company News

Regeneron sends experimental Ebola therapy to Congo

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) said it began shipping its investigational Ebola antibody cocktail REGN-EB3 (REGN3470-3471-3479) to the Democratic Republic of the Congo (DRC). REGN-EB3 was one of several experimental therapies considered for the treatment of Ebola...
07:00 , Mar 23, 2015 |  BC Week In Review  |  Clinical News

Favipiravir: Completed Phase III enrollment

MediVector completed enrollment of 2,021 adults with uncomplicated influenza in the 2 double-blind, placebo-controlled, international Phase III FAVOR trials evaluating oral favipiravir for 5 days. Patients will receive 1,800 mg twice daily on day 1...
08:00 , Dec 8, 2014 |  BC Week In Review  |  Company News

GlaxoSmithKline, European Commission, Institut National de la Sante et de la Recherche Medicale infectious news

The EC will provide €24 million ($29.7 million) to fund five Ebola research projects. The funding includes a €15.2 million ($18.8 million) award to GlaxoSmithKline to conduct European and African clinical trials of ChAd3-EBOV. GSK...
08:00 , Nov 3, 2014 |  BC Week In Review  |  Company News

Fujifilm, MediVector infectious news

Fujifilm's Toyama Chemical Co. Ltd. unit began producing 200 mg Avigan favipiravir in preparation for clinical trials to treat patients with Ebola virus. The governments of France and Guinea will begin human trials...
07:00 , Sep 29, 2014 |  BC Week In Review  |  Clinical News

AVI-7537 regulatory update

EMA's CHMP began a formal review of the available scientific information on Ebola treatments under development. The agency said its goal is to provide an overview of the current state of knowledge about therapies under...
16:18 , Sep 26, 2014 |  BC Extra  |  Politics & Policy

CHMP to review Ebola treatments

EMA has started a review of investigational Ebola treatments. The agency said its goal is to support decision making by health authorities as they decide whether to use experimental treatments in infected patients. The agency...
07:00 , Sep 25, 2014 |  BC Innovations  |  Cover Story

Interrupting Ebola

The 2014 Ebola outbreak is the largest in the disease's history and the first in West Africa, where it has reached multiple countries. Although an approved therapy looks far away, five of seven patients given...
07:00 , Sep 15, 2014 |  BioCentury  |  Product Development

Ebola realities

Hope that experimental Ebola vaccines and therapies might help contain the current outbreak is sliding into hype as public health officials exaggerate how quickly new products could be deployed and minimize the uncertainties inherent in...